RECONSTRUCTION OF URINARY AND GASTROINTESTINAL TRACTS IN TOTAL PELVIC EXENTERATION - EXPERIENCE AT COLUMBIA-PRESBYTERIAN-MEDICAL-CENTER

被引:9
作者
GOLUBOFF, ET
MCKIERNAN, JM
TODD, G
NOWYGROD, R
SMITH, D
OLSSON, CA
机构
[1] COLUMBIA PRESBYTERIAN MED CTR,DEPT UROL,NEW YORK,NY 10034
[2] COLUMBIA PRESBYTERIAN MED CTR,DEPT SURG,NEW YORK,NY 10034
[3] COLUMBIA PRESBYTERIAN MED CTR,DEPT OBSTET & GYNECOL,NEW YORK,NY 10034
关键词
D O I
10.1016/S0090-4295(94)80201-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To examine the effectiveness of and complications from total pelvic exenteration (TPE) with maintenance of urethral and anal sphincter function for locally invasive tumors of the pelvis. Methods. A retrospective review of 4 patients who have undergone TPE with urethral and anal sphincter preservation at Columbia-Presbyterian Medical Center in the last 2 years was performed with attention to perioperative morbidity and mortality, disease-free status, and need for further operative procedures. Results. Two patients had colorectal adenocarcinoma, 1 had squamous cell carcinoma of the cervix, and 1 had prostate sarcoma. All had urinary tract reconstruction with orthotopic neobladder creation, and 3 of 4 had primary low rectal anastomoses for gastrointestinal reconstruction. One patient underwent creation of a J rectal pouch. One of 4 patients had received radiation therapy for the disease prior to surgery. There was no operative or perioperative mortality. Two of 4 patients required reoperation, 1 in the immediate postoperative period for repair of a left ureteral stricture, and the other 13 months postoperatively for repair of a rectal-neobladder fistula. With a mean follow-up of 25 months (range, 21 to 43 months), 3 of 4 patients are alive and free of disease. All living patients are continent of urine and 2 of 5 are continent of stool. Conclusions. Our experience confirms that TPE can be effective in controlling a variety of locally advanced pelvic tumors and can be performed in conjunction with simultaneous genitourinary and gastrointestinal reconstruction with minimal morbidity.
引用
收藏
页码:666 / 670
页数:5
相关论文
共 19 条
[1]   PELVIC EXENTERATION - A MORBIDITY AND MORTALITY ANALYSIS OF A 7-YEAR EXPERIENCE [J].
ANTHOPOULOS, AP ;
MANETTA, A ;
LARSON, JE ;
PODCZASKI, ES ;
BARTHOLOMEW, MJ ;
MORTEL, R .
GYNECOLOGIC ONCOLOGY, 1989, 35 (02) :219-223
[2]  
BARBER HRK, 1969, SURG CLIN N AM, V49, P431
[3]  
BRICKER EM, 1950, SURG CLIN N AM, V30, P1511
[4]  
BRUNSCHWIG A, 1948, CANCER, V1, P177, DOI 10.1002/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO
[5]  
2-A
[6]  
BRUNSCHWIG A, 1951, CANCER, V3, P972
[7]  
CAMEY M, 1988, UROL CLIN N AM, V15, P249
[8]   MORBIDITY AND MORTALITY AFTER PELVIC EXENTERATION FOR COLORECTAL ADENOCARCINOMA [J].
HAFNER, GH ;
HERRERA, L ;
PETRELLI, NJ .
ANNALS OF SURGERY, 1992, 215 (01) :63-67
[9]   PELVIC EXENTERATION WITH LOW RECTAL ANASTOMOSIS - SURVIVAL, COMPLICATIONS, AND PROGNOSTIC FACTORS [J].
HATCH, KD ;
GELDER, MS ;
SOONG, SJ ;
BAKER, VV ;
SHINGLETON, HM .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :462-467
[10]  
KODNER IJ, 1994, PRINCIPLES SURG, P1191